You are here

R&D

Takeda continues global R&D reboot with a new joint venture with PRA

Endpoints

Sat, 04/8/17 - 12:46 pm

Mallinckrodt exits PhRMA before new rules take hold

BioPharma Dive

Thu, 04/6/17 - 11:56 pm

Actelion shareholders OK R&D spinout

Drug Delivery Business News

Wed, 04/5/17 - 12:04 pm

Amgen will move 100 workers to San Francisco, Cambridge as part of restructuring

Bizjournals.com

Tue, 04/4/17 - 12:15 am

Bristol-Myers Squibb Enters Collaboration to Leverage Foundation Medicine’s Molecular Information Platform to Identify Predictive Biomarkers Across Multiple Tumor Types and Immunotherapy Agents

Yahoo

Thu, 03/30/17 - 09:35 am

Bristol-Myers Squibb

Foundation Medicine

Amgen triggers yet another revamp, moving researchers to two big hubs

Endpoints

Mon, 03/27/17 - 10:29 am

Novogen Receives $4.4M R&D Tax Rebate

Yahoo/Benzinga

Mon, 03/27/17 - 09:37 am

That $95M Merck gamble to acquire cCAM? It didn’t pay off.

Endpoints

Fri, 03/24/17 - 10:10 am

Roger Perlmutter

Takeda teams up with venture firm on drug discovery unit

BioPharma Dive

Thu, 03/16/17 - 10:00 pm

drug development

Trump budget calls for slashing biomedical and science research funding

Stat

Thu, 03/16/17 - 10:16 am

research funding

Turning Pfizer Discards Into Novartis Gold: The Story Of Ziarco

Forbes

Wed, 03/15/17 - 10:20 am

drug development

High U.S. drug prices cover pharma's global R&D—and a whole lot more, study finds

Fierce Pharma

Fri, 03/10/17 - 11:41 am

Bristol-Myers' R&D revamp mirrors upheaval in Opdivo's lung cancer fortunes

Fierce Pharma

Fri, 03/10/17 - 09:47 am

Bristol-Myers Squibb

Merck KGaA in talks to sell its biosimilars R&D ops as shakeout looms

Endpoints

Thu, 03/9/17 - 11:36 am

Do big R&D budgets justify US premium drug prices? No way, analysts scoff

Endpoints

Wed, 03/8/17 - 10:44 am

drug development

Google’s venture arm leads Spero’s $51.7M round for R&D work on a pipeline of new antibiotics

Endpoints

Wed, 03/8/17 - 09:57 am

Google Ventures

Doctors Alarmed by Post-antibiotic Future

VOA News

Sun, 03/5/17 - 12:02 pm

antibiotic resistance

drug development

A CRISPR/Cas9 startup launches on the R&D frontier, working on a one-time fix for Duchenne MD

Endpoints

Mon, 02/27/17 - 09:13 am

Duchenne Muscular Dystrophy

Exonics Therapeutics

How could you make a Bristol-Myers takeover work without shredding a $5B R&D division?

Endpoints

Thu, 02/23/17 - 09:24 pm

Bristol-Myers Squibb

5 trends being impacted by biomarkers

BioPharma Dive

Tue, 02/14/17 - 07:39 pm

precision medicine

Pages